Europe adopts cross-border healthcare directive
This article was originally published in Scrip
Executive Summary
The EU Council of Ministers has today approved new legislation on cross-border healthcare. The directive, which includes amendments from the European Parliament, will affect the pharmaceutical industry as it contains provisions that could lead to greater harmonisation on health technology appraisals (HTA).